License-Aware Cloud HPC: Accelerating Discovery with Schrödinger, Cresset, and Posit
Summary Computational chemistry software licenses are among the most expensive line items in a drug discovery budget. When those licenses run on cloud HPC, poor integration creates problems: idle licenses burn money, contention between researchers stalls work, and GPU-heavy notebook sessions run around the clock even when no one is using them. It’s not just […]
Schrödinger at Scale: Enterprise HPC Infrastructure, Deployed in Minutes
Summary BioTeam partnered with a healthcare-focused investment firm whose mission is to advance healthcare innovation by funding innovative, new biotech organizations. These organizations required an automated, secure, scalable, and repeatable cloud-based HPC environment on AWS for their drug discovery pipelines. The client needed a compliant technology foundation that could be deployed at scale across multiple […]
Migration of Comp Chem Applications to Nextflow in AWS
BioTeam partnered with a major hyperscaler to migrate generative AI tools used in computational chemistry workflows to a managed cloud service running Nextflow.
MLOps in Research Environments- AWS Boston Roundtable
Lightning Talk Series: MLOps in Research Environments-AWS Boston Roundtable New users, new data, drift, audits, security, time. All require production-ready thinking. BioTeam’s Senior Scientific Consultant, Wisdom Akpan, covers this clearly in a 5-minute lightning talk on MLOps in Research Environments. Check it out, video linked below. This talk is part of our event Building AI-Ready […]
Using Your Own AI for Data- AWS Boston Roundtable
Lightning Talk Series:Using Your Own AI for Data-AWS Boston Roundtable BioTeam’s Principal Scientific Consultant, Brian Osborne, continues our Lightning Roundtable with a sharp, 5-minute look at what Using Your Own Data for Al really means for scientific teams. Watch his insight into using your own data across cloud, content platforms, personal agents, and on-prem systems […]
Generative AI for Drug Discovery-AWS Boston Roundtable
BioTeam Roundtable Event: Generative AI for Drug Discovery. AWS Boston Roundtable BioTeam’s Senior Scientific Consultant, John Jacquay, kicks off our Lightning Roundtable with a fast-paced look at how Generative AI is reshaping drug discovery. This talk is part of our event Building AI-Ready Infrastructure for Biomedical Research, where four experts unpack what it really takes […]